Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

Erstveröffentlichung

2015

Authors

Pastore, Alessandro

Jurinovic, Vindi

Kridel, Robert

Hoster, Eva

Staiger, Annette M.

et al.

Wissenschaftlicher Artikel

Published in

Lancet Oncology ; 16 (2015), 9. - S. 1111-1122. - ISSN 1470-2045. - eISSN 1474-5488

Link to publication

https://dx.doi.org/10.1016/S1470-2045(15)00169-2

Institutions

UKU. Institut für Pathologie

Subject headings

[Free subject headings]: EZH2 MUTATIONS | RITUXIMAB | CYCLOPHOSPHAMIDE | VINCRISTINE | COMBINATION | DOXORUBICIN | EXPRESSION | LANDSCAPE | IMPACT | DIFFER
[DDC subject group]: DDC 610 / Medicine & health

---

Metadata

Show full item record